Laxido Junior Neutral

Polyethylene glycol 3350 with electrolytes, the active ingredient in Laxido Junior Neutral, is an osmotic laxative presented as an oral solution for oral use. It treats constipation and is employed to prepare the bowel for diagnostic procedures in children and adolescents. The formulation also contains sodium hydrogen carbonate, potassium chloride and sodium chloride to maintain electrolyte balance during treatment.

GNH USA supplies Laxido Junior Neutral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality compliance with EU standards and provides reliable logistics for global distribution.

Laxido Junior Neutral is an osmotic laxative used in the gastrointestinal tract to relieve constipation and to cleanse the colon before medical examinations. - Constipation: provides gentle, water‑based stool softening to facilitate regular bowel movements in children. - Bowel preparation: clears the intestinal lumen to enable clear visualization during diagnostic procedures such as colonoscopy. - Regular bowel habit support: helps maintain normal stool frequency and consistency in pediatric patients with intermittent constipation.

Laxido Junior Neutral may cause adverse reactions, which are generally mild and transient.

Common Side Effects: - Abdominal bloating: feeling of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas. - Nausea: mild sensation of wanting to vomit. - Diarrhoea: loose, watery stools. - Stomach cramps: intermittent abdominal pain. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Severe dehydration: marked loss of body fluids requiring medical attention. - Electrolyte imbalance: abnormal sodium or potassium levels. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Persistent abdominal pain: pain lasting more than 24 hours.

Before using Laxido Junior Neutral, consider the following precautions to ensure safe and effective treatment. - Hydration: maintain adequate fluid intake to support the osmotic action. - Underlying disease: assess for intestinal obstruction or severe inflammatory bowel disease before use. - Electrolyte status: monitor serum electrolytes in patients with renal impairment or on diuretic therapy. - Pediatric dosing: ensure the dose is prescribed by a qualified healthcare professional. - Concomitant laxatives: avoid using other laxatives simultaneously unless directed. - Store at ambient temperature: keep the oral solution below 25°C, in the original container, protected from moisture and direct sunlight.

Laxido Junior Neutral can interact with certain medicines, affecting their absorption or electrolyte balance.

Major Interactions (Avoid): - Sodium‑containing medications: may increase risk of hypernatremia. - Potassium‑sparing diuretics: can lead to elevated potassium levels. - Antacids with high sodium content: may cause excessive sodium load.

Moderate Interactions (Monitor Closely): - Other osmotic laxatives: combined use may cause severe diarrhoea. - Oral rehydration solutions: monitor electrolyte status. - Certain antibiotics (e.g., quinolones): reduced absorption due to altered gut transit.